Natalizumab

Natalizumab

 

 

Recombinant monoclonal antibody to Human ITGA4. Natalizumab is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin. Natalizumab is used in the treatment of multiple sclerosis and Crohn's disease. Natalizumab is administered by intravenous infusion every 28 days. The drug is believed to work by reducing the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and blood–brain barrier. Natalizumab has proven effective in treating the symptoms of both diseases, preventing relapse, vision loss, cognitive decline and significantly improving quality of life in people with multiple sclerosis, as well as increasing rates of remission and preventing relapse in Crohn's disease.

Address :
45-1 Ramsey Road
City :
Shirley
State/Zip, County/PostCode :
11967
Country :
USA

Contact Name :
J.K. Cooper
Telephone :
5166698109
Email :
[email protected]
Website :
http://www.creativebiolabs.net/Anti-Human-ITGA4-Therapeutic-Antibody-Tysabri-13528.htm

Services :
Pharmaceuticals
US Coverage :
All US
UK Coverage :

Clients :

Employees :

Relevant Consulting Services
North Attleboro, USA
Website

The Media Briefcase
Newcastle upon Tyne, UK
Website

Metts Law Firm, LLC
Columbia , USA
Website

Logistics Consulting Firm
Utica, USA
Website

Turner Freeman Lawyers
Sydney, APAC
Website

Strategic Insight Consulting
San Carlos, USA
Website

Adoriasoft
Kharkiv, Europe
Website

OCCHNET LTD
Carmarthen, UK
Website